Vitality Calcium Complete
Natural health product licensed in Canada
- Licence holder
- Melaleuca, Inc.
- NPN or DIN-HM
- 80029641
- Status
- Active licence
- Licence date
- 15 February 2012
- Revision date
- 13 April 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Calcium: up to 1,250 mg a day according to the dosing instructions published by Health Canada (5 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 800 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Hydroxyde de calcium | 250 mg | 1,250,000 µg |
| Calcium Source : Dicalcium phosphate dihydrate | 250 mg | 1,250,000 µg |
| Calcium Source : Citrate de calcium tétrahydraté | 250 mg | 1,250,000 µg |
| Calcium Source : Carbonate de calcium | 250 mg | 1,250,000 µg |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose gum, Cire de Carnauba, Citrate de potassium, Acide stéarique, Glycine, Hydroxypropylcellulose, Hydroxy methyl cellulose, Stéarate de magnésium, Inuline, Poly(éthylène glycol), Acide L-aspartique, Microcrystalline cellulose, Saveur de vanille naturelle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | minimum: 18 years ; maximum: 49 years | 3 Comprimé | 1 Tous les jours |
| Adultes | minimum: 50 years | 5 Comprimé | 1 Tous les jours |
| Adultes de sexe féminin | minimum: 18 years ; maximum: 49 years | 4 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Calcium intake, when combined with sufficient vitamin D, a healthy diet and regular exercise, may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80029641
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging